6D7L
Cytoplasmic domain of TRPC3
6D7L の概要
| エントリーDOI | 10.2210/pdb6d7l/pdb |
| EMDBエントリー | 7823 |
| 分子名称 | Short transient receptor potential channel 3 (1 entity in total) |
| 機能のキーワード | trp channel, ion channel, membrane protein, cerebellum, moonwalker, transport protein |
| 由来する生物種 | Homo sapiens (Human) |
| タンパク質・核酸の鎖数 | 4 |
| 化学式量合計 | 391477.12 |
| 構造登録者 | Sierra-Valdez, F.J.,Azumaya, C.M.,Nakagawa, T.,Cordero-Morales, J.F. (登録日: 2018-04-25, 公開日: 2018-08-29, 最終更新日: 2024-03-13) |
| 主引用文献 | Sierra-Valdez, F.,Azumaya, C.M.,Romero, L.O.,Nakagawa, T.,Cordero-Morales, J.F. Structure-function analyses of the ion channel TRPC3 reveal that its cytoplasmic domain allosterically modulates channel gating. J. Biol. Chem., 293:16102-16114, 2018 Cited by PubMed Abstract: The transient receptor potential ion channels support Ca permeation in many organs, including the heart, brain, and kidney. Genetic mutations in transient receptor potential cation channel subfamily C member 3 (TRPC3) are associated with neurodegenerative diseases, memory loss, and hypertension. To better understand the conformational changes that regulate TRPC3 function, we solved the cryo-EM structures for the full-length human TRPC3 and its cytoplasmic domain (CPD) in the apo state at 5.8- and 4.0-Å resolution, respectively. These structures revealed that the TRPC3 transmembrane domain resembles those of other TRP channels and that the CPD is a stable module involved in channel assembly and gating. We observed the presence of a C-terminal domain swap at the center of the CPD where horizontal helices (HHs) transition into a coiled-coil bundle. Comparison of TRPC3 structures revealed that the HHs can reside in two distinct positions. Electrophysiological analyses disclosed that shortening the length of the C-terminal loop connecting the HH with the TRP helices increases TRPC3 activity and that elongating the length of the loop has the opposite effect. Our findings indicate that the C-terminal loop affects channel gating by altering the allosteric coupling between the cytoplasmic and transmembrane domains. We propose that molecules that target the HH may represent a promising strategy for controlling TRPC3-associated neurological disorders and hypertension. PubMed: 30139744DOI: 10.1074/jbc.RA118.005066 主引用文献が同じPDBエントリー |
| 実験手法 | ELECTRON MICROSCOPY (4 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






